Free Trial
MarketBeat All Access — Now with A.I. InsightsTry It Free

EssilorLuxottica (ESLOY) Stock Forecast & Price Target

EssilorLuxottica logo
$158.10 -2.12 (-1.32%)
As of 10/10/2025 04:00 PM Eastern
Compare

EssilorLuxottica - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Hold
Based on 3 Analyst Ratings
Sell
0
Hold
2
Buy
1

Based on 3 Wall Street analysts who have issued ratings for EssilorLuxottica in the last 12 months, the stock has a consensus rating of "Hold." Out of the 3 analysts, 2 have given a hold rating, and 1 has given a buy rating for ESLOY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for ESLOY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for EssilorLuxottica and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ESLOY Analyst Ratings Over Time

TypeCurrent Forecast
10/12/24 to 10/12/25		1 Month Ago
9/12/24 to 9/12/25		3 Months Ago
7/14/24 to 7/14/25		1 Year Ago
10/13/23 to 10/12/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
 N/A
Buy
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
 N/A
Hold
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
 N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
 N/A
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus RatingHoldHoldHoldN/A

ESLOY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ESLOY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

EssilorLuxottica Stock vs. The Competition

TypeEssilorLuxotticaMedical CompaniesS&P 500
Consensus Rating Score
2.33
2.33
2.52
Consensus RatingHoldHoldModerate Buy
Predicted UpsideN/A1,022.61% Upside177.78% Upside
News Sentiment Rating
Positive News

See Recent ESLOY News
Positive News
Positive News
Export to Excel
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
9/10/2025Zacks Research
0 of 5 stars		 UpgradeStrong Sell ➝ Hold
9/9/2025Barclays
3 of 5 stars		 Initiated CoverageOverweight
1/29/2025Royal Bank Of Canada
3 of 5 stars
P. Dadhania
P. Dadhania
Not Rated
UpgradeHold ➝ Moderate Buy
12/3/2024UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
S. Tibaldi
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
DowngradeBuy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:55 AM ET.


Should I Buy EssilorLuxottica Stock? ESLOY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, October 11, 2025. Please send any questions or comments about these EssilorLuxottica pros and cons to contact@marketbeat.com.

EssilorLuxottica
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in EssilorLuxottica Société anonyme:

  • The stock has recently seen a significant increase in trading volume, indicating heightened investor interest and potential for price movement.
  • EssilorLuxottica Société anonyme's current stock price is around $166, reflecting a positive trend compared to previous trading sessions.
  • Analysts have upgraded the stock from a "strong sell" to a "hold" rating, suggesting improved sentiment and potential for stability.
  • The company operates in a growing market for ophthalmic lenses and eyewear, with a diverse product range appealing to various consumer segments.
  • With a debt-to-equity ratio of 0.17, the company maintains a strong balance sheet, indicating lower financial risk and greater stability for investors.

EssilorLuxottica
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in EssilorLuxottica Société anonyme for these reasons:

  • Despite recent upgrades, the stock has a consensus rating of "Hold," which may indicate limited upside potential in the near term.
  • Trading volume fluctuations can lead to volatility, which may pose risks for investors looking for stable returns.
  • The stock has experienced price fluctuations, with recent trading showing a decline from previous highs, which could signal uncertainty.
  • Market conditions can impact consumer spending on eyewear, potentially affecting sales and profitability.
  • While the company has a solid balance sheet, the quick ratio of 0.65 suggests that it may face challenges in meeting short-term obligations without additional financing.

ESLOY Forecast - Frequently Asked Questions

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for EssilorLuxottica in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ESLOY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ESLOY, but not buy additional shares or sell existing shares.

According to analysts, EssilorLuxottica's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, EssilorLuxottica's stock had 1 upgrade by analysts.

EssilorLuxottica has been rated by research analysts at Barclays, and Zacks Research in the past 90 days.

Analysts like EssilorLuxottica more than other "medical" companies. The consensus rating score for EssilorLuxottica is 2.33 while the average consensus rating score for "medical" companies is 2.33. Learn more on how ESLOY compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (OTCMKTS:ESLOY) was last updated on 10/12/2025 by MarketBeat.com Staff
From Our Partners
URGENT: The Market's 3 Red Flags Are Flashing
Here’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...
StockEarnings | Sponsoredtc pixel
Trump Devises the Death of the IRS ☠️
Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...
Angel Publishing | Sponsoredtc pixel
1 Hour Once A Day
My top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...
Base Camp Trading | Sponsoredtc pixel
Trump’s “Smart Dollar” just went mainstream
"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...
Stansberry Research | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
Is your money positioned for what’s coming?
The 7 red flags Wall Street won’t talk about
American Alternative | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel